Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare Co is positioned for improving fundamentals because its behavioral healthcare model benefits from strong structural demand, a diversified mix of acute, specialty, CTC, and residential services, and a majority of revenue coming from acute inpatient psychiatric facilities in the United States. The company’s outlook is also supported by rising EBITDA expectations, with 2026 forecast at $595m to $599.8m and 2027 estimates lifted to roughly $640m to $704m as one-time malpractice expense rolls off, startup costs fall, and ramping facilities contribute more meaningfully. Management’s tighter operational discipline, renewed focus on G&A efficiencies, and potential upside from Florida DPP further strengthen confidence that margins and cash flow can improve even as bad debt and denial issues remain contained.

Acadia Healthcare Co is viewed negatively because its business appears to be in a pattern of deterioration, with operations likely to get worse before better amid soft volumes, specialty revenue declines of 6.6%, and a $3.7 million EBITDA drag from weather-related CTC disruptions in 1Q26. The outlook is further pressured by significant legal and regulatory liabilities, including continued headline risk from improper admission practices and government-investigation exposure, while elevated payor denials and Medicaid/referral disruptions add uncertainty to reimbursement and payer mix. Despite management’s efforts to improve appeals, staffing, and reorganization, the company still faces rising clinical costs, de novo execution risk, and skepticism that free cash flow is improving meaningfully enough to offset these headwinds.